Regulatory B cells and tolerance in transplantation: From animal models to human

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Chesneau, Mélanie ^a,b   Michel, Laure ^a,c   Degauque, Nicolas ^a   Brouard, Sophie ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Animal; Human; Regulatory B cells; Tolerance; Transplantation; Treatment

Indexed keywords

EID: 84892143731     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00497     Document Type: Review

References (65)

1. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant (2006) 6:1774-80. doi: 10.1111/j.1600-6143.2006.01396.x
2. Orlando G, Hematti P, Stratta RJ, Burke GW III, Di Cocco P, Cocco PD, et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg (2010) 252:915-28. doi:10.1097/SLA.0b013e3181f3efb0
3. Brouard S, Pallier A, Renaudin K, Foucher Y, Danger R, Devys A, et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 104:15448-53. doi:10.1111/j.1600-6143.2012.04249.x
4. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 120:1836-47. doi:10.1172/JCI39933
5. Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 120:1848-61. doi:10.1172/JCI39922
6. Roussey-Kesler G, Giral M, Moreau A, Subra J-F, Legendre C, Noël C, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant (2006) 6:736-46. doi:10.1111/j.1600-6143.2006.01280.x
7. Cobbold SP, Adams E, Graca L, Daley S, Yates S, Paterson A, et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol Rev (2006) 213:239-55. doi:10.1111/j.1600-065X.2006.00428.x
8. Clatworthy MR. Targeting B cells and antibody in transplantation. Am J Transplant (2011) 11:1359-67. doi:10.1111/j.1600-6143.2011.03554.x
9. Stegall MD, Raghavaiah S, Gloor JM. The (re)emergence of B cells in organ transplantation. Curr Opin Organ Transplant (2010) 15:451-5. doi:10.1097/MOT.0b013e32833b9c11
10. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 1:475-82. doi:10.1038/82717
11. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol (2001) 1:147-53. doi:10.1038/35100573
12. Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 251:550-1. doi:10.1038/251550a0
13. Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol (1974) 113:1716-25.
14. Wolf SD, Dittel BN, Hardardottir F, Janeway CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 184:2271-78.
15. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol (2007) 178:7868-78.
16. Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity (2008) 28:639-50. doi:10.1016/j.immuni.2008.03.017
17. Bouaziz J-D, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev (2008) 224:201-14. doi:10.1111/j.1600-065X.2008.00661.x
18. Hagn M, Jahrsdörfer B. Why do human B? cells secrete granzyme B? Insights into a novel B-cell differentiation pathway. Oncoimmunology (2012) 1:1368-75. doi:10.4161/onci.22354
19. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 3:944-50. doi:10.1038/ni833
20. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 197:489-501. doi:10.1084/jem.20021293
21. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderón Gómez E, Sweenie CH, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol (2008) 180:4763-73.
22. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature (2012) 491:264-8. doi:10.1038/nature11501
23. Matsushita T, Horikawa M, Iwata Y, Tedder TF. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol (2010) 185:2240-52. doi:10.4049/jimmunol.1001307
24. Maseda D, Smith SH, DiLillo DJ, Bryant JM, Candando KM, Weaver CT, et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol (2012) 188:1036-48. doi:10.4049/jimmunol.1102500
25. Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Mégret J, Ezine S, et al. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A (2013) 110:E2199-208. doi:10.1073/pnas.1222446110
26. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol (2009) 182:3492-502. doi:10.4049/jimmunol.0803052
27. Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest (2008) 118:3420-30. doi:10.1172/JCI36030
28. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Muñoz-Suano A, Kamanaka M, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol (2011) 186:5569-79. doi:10.4049/jimmunol.1100284
29. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol (2007) 178:3447-56.
30. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, Katano R, et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol (2009) 21:843-58. doi:10.1093/intimm/dxp050
31. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 32:129-40. doi:10.1016/j.immuni.2009.11.009
32. Lemoine S, Morva A, Youinou P, Jamin C. Human T cells induce their own regulation through activation of B cells. J Autoimmun (2011) 36:228-38. doi:10.1016/j.jaut.2011.01.005
33. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2011) 117:530-41. doi:10.1182/blood-2010-07-294249
34. Morva A, Lemoine S, Achour A, Pers J-O, Youinou P, Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood (2012) 119:106-14. doi:10.1182/blood-2011-06-360768
35. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, et al. Survival of mouse pancreatic isletallografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A (1995) 92:9560-4. doi:10.1073/pnas.92.21.9560
36. Niimi M, Pearson TC, Larsen CP, Alexander DZ, Hollenbaugh D, Aruffo A, et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol (1998) 161:5331-7.
37. Yan Y, van der Putten K, Bowen DG, Painter DM, Kohar J, Sharland AF, et al. Postoperative administration of donor B cells induces rat kidney allograft acceptance: lack of association with Th2 cytokine expression in long-term accepted grafts. Transplantation (2002) 73:1123-30. doi:10.1097/00007890-200204150-00020
38. Deng S, Moore DJ, Huang X, Lian M-M, Mohiuddin M, Velededeoglu E, et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol (2007) 178:6028-32.
39. Huang X, Moore DJ, Mohiuddin M, Lian M-M, Kim JI, Sonawane S, et al. Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance. Transplantation (2008) 85:675-80. doi:10.1097/TP.0b013e3181663422
40. Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE, O'Connor MR, et al. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant (2010) 10:796-801. doi:10.1111/j.1600-6143.2010.03027.x
41. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest (2011) 121:3645-56. doi:10.1172/JCI46274
42. Le Texier L, Thebault P, Lavault A, Usal C, Merieau E, Quillard T, et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant (2011) 11:429-38. doi:10.1111/j.1600-6143.2010.03336.x
43. Lee KM, Kim JI, Stott R, Soohoo J, O'Connor MR, Yeh H, et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant (2012) 12:2072-78. doi:10.1111/j.1600-6143.2012.04055.x
44. Louis S, Braudeau C, Giral M, Dupont A, Moizant F, Robillard N, et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation (2006) 81:398-407. doi:10.1097/01.tp.0000203166.44968.86
45. Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh S, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 104:15448-53. doi:10.1073/pnas.0705834104
46. Pallier A, Hillion S, Danger R, Giral M, Racapé M, Degauque N, et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int (2010) 78:503-13. doi:10.1038/ki.2010.162
47. Danger R, Thervet E, Grisoni M-L, Puig PL, Pallier A, Tregouet D, et al. PARVG gene polymorphism and operational renal allograft tolerance. Transplant Proc (2012) 44:2845-8. doi:10.1016/j.transproceed.2012.09.034
48. Silva HM, Takenaka MCS, Moraes-Vieira PMM, Monteiro SM, Hernandez MO, Chaara W, et al. Preserving the B cell compartment favors operational tolerance in human renal transplantation. Mol Med (2012) [cited 2012 Jun 8]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22252714 doi:10.2119/molmed.2011.00281
49. Haynes LD, Jankowska-Gan E, Sheka A, Keller MR, Hernandez-Fuentes MP, Lechler RI, et al. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant (2012) [cited 2012 Feb 9]. Available from: http://onlinelibrary.wiley.com.gate2.inist.fr/doi/10.1111/j.1600-6143.2011.03869.x/abstract doi:10.1111/j.1600-6143.2011.03869.x
50. Chesneau M, Pallier A, Braza F, Lacombe G, Le Gallou S, Baron D, et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant (2013). doi:10.1111/ajt.12508
51. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci U S A (1991) 88:2037-41. doi:10.1073/pnas.88.6.2037
52. Moore DJ, Huang X, Lee MK IV, Lian M-M, Chiaccio M, Chen H, et al. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved. Transpl Int (2004) 17:261-9. doi:10.1111/j.1432-2277.2004.tb00440.x
53. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev (2010) 235:172-89. doi:10.1111/j.0105-2896.2010.00903.x
54. Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, Boenisch O, et al. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest (2008) 118:742-51. doi:10.1172/JCI32451
55. Aiba Y, Yamazaki T, Okada T, Gotoh K, Sanjo H, Ogata M, et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity (2006) 24:259-68. doi:10.1016/j.immuni.2006.01.002
56. Kozyrev SV, Abelson A-K, Wojcik J, Zaghlool A, Linga Reddy MP, Sanchez E, et al. Corrigendum: functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet (2008) 40:484. doi:10.1038/ng0408-484
57. McGaha TL, Karlsson MCI, Ravetch JV. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol (2008) 180:5670-9.
58. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, Churg A, et al. alpha1-Antitrypsin monotherapy induces immune tolerance during isletallograft transplantation in mice. Proc Natl Acad Sci U S A (2008) 105:16236-41. doi:10.1073/pnas.0807627105
59. Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, Lewis EC. α-1-Antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents isletallograft rejection. Mol Med (2011) 17:1000-11. doi:10.2119/molmed.2011.00145
60. Nouël A, Ségalen I, Jamin C, Doucet L, Caillard S, Renaudineau Y, et al. B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection. Kidney Int (2013) [cited 2013 Nov 29]. Available from: http://www.nature.com/ki/journal/vaop/ncurrent/full/ki2013457a.html doi:10.1038/ki.2013.457
61. Porcheray F, Wong W, Saidman SL, De Vito J, Girouard TC, Chittenden M, et al. B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant (2009) 9:2126-35. doi:10.1111/j.1600-6143.2009.02738.x
62. Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J Hepatol (2009) 50:1247-57. doi:10.1016/j.jhep.2009.03.006
63. Martínez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 7:309-19. doi:10.1111/j.1600-6143.2006.01621.x
64. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, López M, Giral M, et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 11:1916-26. doi:10.1111/j.1600-6143.2011.03638.x
65. Jamin C, Achour A, Youinou P, Pers J-O. Regulatory lymphocytes: a new cooperation between T and B cells for a better control of the immune response. Presse Med (2013). doi:10.1016/j.lpm.2013.02.332